Cargando…
Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health
Chronic kidney disease (CKD) affects 8–16% of the population worldwide. In developed countries, the most important risk factors for CKD are diabetes, hypertension, and obesity, calling into question the importance of educating and acting on lifestyles and nutrition. A balanced diet and supplementati...
Autores principales: | Cosola, Carmela, Sabatino, Alice, di Bari, Ighli, Fiaccadori, Enrico, Gesualdo, Loreto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073437/ https://www.ncbi.nlm.nih.gov/pubmed/29937486 http://dx.doi.org/10.3390/nu10070808 |
Ejemplares similares
-
Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-cresol Sulfate in Hemodialysis Patients: Results from an In Vitro Study and an In Vivo Pilot Trial (xuanro4-Nature 3.2)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2020) -
Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2021) -
Why stem/progenitor cells lose their regenerative potential
por: Picerno, Angela, et al.
Publicado: (2021) -
Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2019) -
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
por: Cosola, Carmela, et al.
Publicado: (2021)